# NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery

> **NCT07382479** · NA · NOT_YET_RECRUITING · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 485 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **PROCEDURE:** 3 cycles of NACT with unfavorable KELIM score will receive 3 more cycles of NACT followed by DIDS
- **PROCEDURE:** 3 cycles of NACT with favorable KELIM score will undergo IDS followed by 3 cycles of NACT

## Key facts

- **NCT ID:** NCT07382479
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2031-04-01
- **Final completion:** 2034-04-01
- **Target enrollment:** 485 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07382479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07382479, "NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07382479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*